Aorto-Iliac Occlusive Disease Treatment Market Size, Share & Trends Analysis Report Device Type (Endovascular Devices, Surgical Devices), By Procedure (Endovascular Procedures, Hybrid Procedures, Open Surgical Procedures), By End Use (Hospitals, Outpatient Facilities, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Aorto-Iliac Occlusive Disease Treatment Market Size & Growth Analysis

The global aorto-iliac occlusive disease treatment market size was valued at USD 2.09 billion in 2025 and is projected to grow from USD 2.20 billion in 2026 to USD 3.26 billion by 2034, registering a CAGR of 5.06% during the forecast period from 2026 to 2034. North America dominated the aorto-iliac occlusive disease treatment market with a market share of 54% in 2025.

The aorto-iliac occlusive disease treatment market encompasses medical devices, procedures, and care settings focused on the management of obstructive atherosclerotic disease affecting the distal abdominal aorta and iliac arteries. This market includes endovascular devices such as balloon angioplasty systems, atherectomy platforms, and a broad range of stents, including self-expanding stents, balloon expandable stents, covered stent grafts, and bifurcated aortic stent grafts designed to restore arterial patency and improve lower limb perfusion. Surgical devices used in open reconstruction procedures also form part of the market for patients requiring direct arterial repair. Treatment approaches are categorized into endovascular procedures, including balloon angioplasty, primary stenting, kissing stent techniques, covered stent graft placement, and endovascular aortic repair, as well as hybrid procedures that combine open and endovascular methods and conventional open surgical procedures. End-use settings include hospitals, outpatient facilities, and other specialized vascular care centers that deliver diagnostic evaluation, interventional therapy, and post-procedure management for aorto-iliac occlusive disease.

Device Type Insights

The endovascular devices segment dominated the market in 2025 due to the broad utilization of balloon angioplasty devices, atherectomy systems, and stents in iliac artery revascularization procedures. High procedural preference for self-expanding stents, balloon expandable stents, covered stent grafts, and bifurcated aortic stent grafts supports the dominance of this segment, as these devices align with minimally invasive treatment strategies for complex iliac lesions.

The surgical devices segment is anticipated to register the fastest growth during the forecast period, accounting for a growth rate of 6.12%. Growth is driven by the continued clinical relevance of open surgical reconstruction in patients with advanced occlusive disease unsuitable for endovascular intervention.

Request Customizationto receive a tailored report.

Procedure Insights

The endovascular procedures segment dominated the market in 2025, representing a revenue share of 63.24%. Dominance is supported by widespread adoption of balloon angioplasty, primary stenting, kissing stent techniques, covered stent graft placement, and endovascular aortic repair for aorto iliac disease management. Preference for reduced recovery time and lower perioperative burden supports sustained procedural volumes.

The hybrid procedures segment is expected to witness the fastest growth with a growth rate of 6.34%. Expansion is supported by increasing use of combined open and endovascular approaches to address complex multilevel occlusive disease.

End Use Insights

The hospitals segment dominated the market in 2025 with a revenue share of 50.23%. Availability of advanced imaging systems, specialized vascular teams, and the capacity to manage high complexity cases support hospital-based treatment dominance.

The outpatient facilities segment is anticipated to grow at the fastest rate, accounting for a growth rate of 6.78%. Growth is supported by the gradual transition of selected endovascular interventions toward outpatient settings that emphasize procedural efficiency and shorter recovery duration.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America Market Insights

North America held the leading share of 44.54% in the aorto iliac occlusive disease treatment market in 2025, supported by high utilization of peripheral revascularization procedures across tertiary vascular centers. Strong penetration of catheter-based interventions and structured referral pathways from primary care to vascular specialists support steady procedural volumes.

The U.S. market is driven by widespread use of ankle brachial index screening and advanced vascular imaging in patients with peripheral arterial disease, supporting timely adoption of stent placement and surgical bypass procedures across hospital networks.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Market Insights

Asia Pacific is projected to record a rapid expansion of 7.06% during the forecast period due to rising diagnoses of peripheral arterial disease and increasing availability of vascular surgery services in metropolitan hospitals. Growth is supported by the expansion of interventional cardiology departments and rising clinician preference for minimally invasive limb revascularization approaches.

China's market growth is driven by increasing use of locally manufactured vascular stents within public hospitals, combined with growing procedural expertise in high volume urban medical centers.

Europe Aorto Market Insights

Europe demonstrates steady growth supported by established treatment algorithms for peripheral arterial disease and strong coordination between vascular surgeons and interventional radiologists. Reimbursement coverage for endovascular and open procedures supports consistent adoption across public healthcare systems.

German market is driven by routine vascular risk assessment in aging populations, leading to sustained demand for iliac artery stents and surgical reconstruction procedures.

Latin America Market Insights

Latin America is witnessing a gradual expansion supported by the growing availability of vascular specialty services within private hospitals. Increasing investment in angiography suites and trained specialists supports the adoption of endovascular interventions in major cities.

Brazil market growth is driven by rising referrals to tertiary hospitals for advanced peripheral artery disease management, supporting uptake of iliac stenting procedures.

Middle East and Africa Aorto Market Insights

The Middle East and Africa market is developing steadily as healthcare systems expand advanced vascular treatment capacity. Adoption remains concentrated within referral hospitals managing complex peripheral arterial disease cases.

Saudi Arabia market is driven by public investment in specialized cardiovascular centers, enabling broader access to endovascular and surgical treatment options for aorto iliac occlusive disease.

Competitive Landscape

The global aorto-iliac occlusive disease treatment market is moderately fragmented, with established cardiovascular device manufacturers and specialized peripheral vascular solution providers competing across hospital-based vascular surgery and interventional cardiology settings. Market participants focus on portfolio depth across stents, catheters, and surgical grafts, alongside clinician training and procedural support initiatives.

Medtronic plc: An emerging market player

Medtronic holds a strong position in the aorto-iliac occlusive disease treatment market through its broad range of peripheral vascular stents, balloons, and access systems. The company emphasizes device versatility to address complex lesion morphology and calcified vessels. Its strategy centers on expanding clinical adoption through long-term physician engagement, evidence generation, and alignment with evolving peripheral artery disease treatment protocols. Continuous refinement of delivery platforms and integration across endovascular workflows support Medtronic’s competitive positioning across global vascular care markets.

List of Key and Emerging Players in Aorto-Iliac Occlusive Disease Treatment Market